A plain-language guide

hereditary spastic paraplegia

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Early map · 8 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. hereditary spastic paraplegia is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's hereditary spastic paraplegia?

Hereditary spastic paraplegia is a group of rare inherited neurodegenerative disorders that cause progressive weakness and spasticity of the lower limbs, from degeneration of the corticospinal tracts.

Features mapped6
Treatments mapped1
Published sources7
Last reviewed2026-08-04

Signs and symptoms

Lower limb muscle weakness

Progressive weakness of the lower limbs accompanies the spasticity of hereditary spastic paraplegia.

Limited evidenceSource: PMID:42116150
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:42116150 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:42116150 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Hyperreflexia

Hyperreflexia (overactive reflexes), reflecting corticospinal tract involvement, is characteristic of hereditary spastic paraplegia, alongside lower-limb stiffness.

Limited evidenceSource: PMID:42277908
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:42277908 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:42277908 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Urinary bladder sphincter dysfunction

Bladder dysfunction is among the most prominent features of hereditary spastic paraplegia, sometimes with mild sensory changes.

Limited evidenceSource: PMID:41507865
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:41507865 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:41507865 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Lower limb spasticity

Progressive spasticity (stiffness) of the lower limbs is a core feature of hereditary spastic paraplegia.

Limited evidenceSource: PMID:42026498
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:42026498 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:42026498 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Spastic paraplegia

Spastic paraparesis, spasticity and weakness of the legs, is among the most prominent features of hereditary spastic paraplegia.

Limited evidenceSource: PMID:41507865
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:41507865 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:41507865 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Spastic gait

A spastic gait, walking made stiff and effortful by leg spasticity, has been described in a person with hereditary spastic paraplegia.

Limited evidenceSource: PMID:41327477
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:182601
Notesplain_language confirmed from PMID:41327477 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary OMIM:182601 -> PMID:41327477 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

botulinum toxin

Botulinum toxin injections are used to reduce lower-limb spasticity in hereditary spastic paraplegia.

Used to help with: Lower limb spasticity.

Limited evidenceSource: PMID:37073790
The source text this rests on
“…online spasticity monitoring tool amongst people with hereditary spastic paraplegia or chronic stroke receiving botulinum toxin…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed via curation 2026-07-03; re-pointed to symptom target
Last reviewed2026-07-03

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 7 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

PMID:37073790 · Online monitoring of focal spasticity treatment with botulinum toxin in people with chronic conditions.
PMID:41150204 · Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update.
PMID:41327477 · Clinical characteristics and gene mutation analysis of a family with hereditary spastic paraplegia type 11: a case report.
PMID:41507865 · Subclinical involvement of central nervous system structures other than motor or sensory tracts in SPG3A and SPG4 patients.
PMID:42026498 · Genotypic and phenotypic spectrum of hereditary spastic paraplegia 56: insights from novel CYP2U1 variants and a literature review.
PMID:42116150 · New insights into HPDL protein: identification of a novel Bi-allelic variant, docking simulation study, and literature review.
PMID:42277908 · Coenzyme Q4 gene compound heterozygous mutations cause hereditary spastic paraplegias: a case report.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.